Mirum Pharmaceuticals Showcases Leadership in Liver Disease Innovation With Data From LIVMARLI® and Volixibat Clinical Programs at AASLD's The Liver Meeting®
Mirum(US:MIRM) Businesswire·2025-11-07 21:10公司动态 - 公司在AASLD的The Liver Meeting®上展示了其在肝脏疾病创新领域的领导力 [1] - 展示的数据涵盖LIVMARLI®和Volixibat临床项目 [1]